Our data may pave the way for future studies aimed at more deeply assessing its role in other cancer hallmarks, further providing a solid rationale to propose NKX3-2 as a novel therapeutic target in the tumors overexpressing NKX3-2. The gene discussed is NKX3-2; the disease is cancer.